Advanced search
Publication Cover
Neuro-Ophthalmology Latest Articles
Submit an article Journal homepage
45
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Fulminant Idiopathic Intracranial Hypertension Should Be Redefined Without a Time Limited Definition

In reply to: Characterisation and visual outcomes of fulminant idiopathic intracranial hypertension: a narrative review

Vaishnavi Menona Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UKORCID Iconhttps://orcid.org/0000-0002-3960-0535View further author information
ORCID Icon,
Michael Stormly Hansenb Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Kobenhavn, DenmarkView further author information
&
Susan P. Mollana Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;c Translational Brain Science, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6314-4437View further author information
ORCID Icon
Published online: 19 Apr 2024

References

  • Shaia JK, Sharma N, Kumar M, et al. Changes in prevalence of idiopathic intracranial hypertension in the United States between 2015 and 2022, stratified by sex, race, and ethnicity. Neurology. 2024;102(3):e208036. doi:10.1212/WNL.0000000000208036.
  • Adderley NJ, Subramanian A, Nirantharakumar K, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76(9):1088–1098. doi:10.1001/jamaneurol.2019.1812.
  • Shaia JK, Markle J, Das N, Singh RP, Talcott KE, Cohen D. Characterisation and visual outcomes of fulminant idiopathic intracranial hypertension: a narrative review. Neuro-Ophthalmology. doi:10.1080/01658107.2023.2301358.
  • Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–1165. doi:10.1212/WNL.0b013e3182a55f17. Epub 2013 Aug 21. PMID: 23966248.
  • Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68(3):229–232. doi:10.1212/01.wnl.0000251312.19452.ec. PMID: 17224579.
  • Lyons HS, Mollan SLP, Liu GT, et al. Different characteristics of pre-pubertal and post-pubertal idiopathic intracranial hypertension: a narrative review. Neuro-Ophthalmology. 2022;47(2):63–74. doi:10.1080/01658107.2022.2153874.
  • Mollan SP, Fraser CL, Digre KB, et al. Guidelines of the international headache society for controlled clinical trials in idiopathic intracranial hypertension. Cephalalgia. 2023;43(8):3331024231197118. doi:10.1177/03331024231197118.
  • Mollan SP, Sinclair AJ. Outcomes measures in idiopathic intracranial hypertension. Expert Rev Neurother. 2021;21(6):687–700. doi:10.1080/14737175.2021.1931127.
  • Kobeissi H, Bilgin C, Ghozy S, et al. Common design and data elements reported on idiopathic intracranial hypertension trials: a systematic review. J Neuroophthalmol. 2024;44(1):66–73. doi:10.1097/WNO.0000000000001902.
  • Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019;33(3):478–485. doi:10.1038/s41433-018-0238-5.
  • Hyder YF, Homer V, Thaller M, et al. Defining the phenotype and prognosis of people with idiopathic intracranial hypertension after cerebrospinal fluid diversion surgery. Am J Ophthalmol. 2023;250:70–81. doi:10.1016/j.ajo.2023.01.016. Epub 2023 Jan 20. PMID: 36682516.
  • Thaller M, Tsermoulas G, Sun R, Mollan SP, Sinclair AJ. Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2021;92(7):795–797. doi:10.1136/jnnp-2020-325519.
  • Eggenberger ER, Costello F, Frohman E, Pless M, Stavern GV. Precision terminology – why to avoid the term “atypical optic neuritis”. Neurology. 2022;99(24):1108–1109. doi:10.1212/wnl.0000000000201474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.